t.steenkamp
TL2 Member · Lund, SE
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 5 September 2025 · last posted 20d · groups: regional-eu
76 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions — does this still hold? Replied, post #23 · Access › Shortages · 8 Jul 2026 · 6 likes Building on post #22 rather than restating it. Both are useful and different. The notice tells you the national position; the account tells you what is happening on the…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #93 · Sourcing › Vendor reports · 30 Jun 2026 · 29 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Request: a per-category review queue Replied, post #65 · Meta › Feature requests · 28 Jun 2026 · 0 likes I read post #61 twice before replying, because I had assumed the opposite. Adding the boring version of per-category review queue, because the interesting version keeps…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #129 · Practice › Interactions · 19 Jun 2026 · 7 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Tracking intake honestly when appetite is absent Replied, post #62 · Nutrition & Training › Protein & intake · 16 Jun 2026 · 21 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #50 · Sourcing › Red flags · 4 Jun 2026 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #42 · Analytics › Method validation · 4 Jun 2026 · 0 likes Forced degradation under acid, base, oxidation, heat and light is how specificity is actually demonstrated. The chromatograms from that work are more informative than…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #58 · Practice › Reconstitution · 17 May 2026 · 7 likes Confirming post #57 from a second method, which matters more than confirming it from a second person. A vial that will not fully dissolve: check in order: is the…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #127 · Compounds › Tirzepatide · 16 May 2026 · 18 likes Building on post #126 rather than restating it. What I would check first on 2.5 mg starting dose is whether the thing being measured moved or whether the way of…
-
Constipation management, with a dietitian's contribution Replied, post #64 · Practice › Side effects · 12 May 2026 · 33 likes Worth separating two things that post #62 runs together. Reading back through the constipation management threads from last year, the same three questions come up every…
-
Step therapy requirements and how to satisfy them Replied, post #14 · Access › Insurance & coverage · 9 May 2026 · 3 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Happy to be the one who is wrong…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #58 · Clinical › Bloodwork · 5 May 2026 · 17 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #13 · Analytics › Home & field testing · 3 May 2026 · 2 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.…
-
Second pass at: Cagrilintide molecular characteristics and analytical considerations Started this topic · Compounds › Cagrilintide & amylin analogues · 1 May 2026 · 0 likes On the subject in the title: Second pass at: Cagrilintide molecular characteristics and analytical considerations Working notes rather than a conclusion. Something…
-
Five questions in one post gets you one answer — how to split them Replied, post #65 · Start Here › How to Ask · 26 Apr 2026 · 0 likes Post #63 is right about the mechanism and I think understates the practical bit. Context that matters: compound, how long in, current dose, relevant history. Context…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #84 · Analytics › Mass spectrometry · 15 Apr 2026 · 25 likes On post #80 — agreed on the reasoning, with one qualification. Charge states is well covered in the tag pages, and the older discussions are better than the recent ones…
-
Shakes versus food: a pragmatic assessment Replied, post #4 · Nutrition & Training › Protein & intake · 14 Apr 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once. It is a small…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #40 · Sourcing › Logistics · 12 Apr 2026 · 22 likes Coming back to post #38, because the follow-up matters more than the original answer. Import restrictions by jurisdiction: what is legal to import for personal use…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #37 · Data & Tools › Calculators · 6 Apr 2026 · 0 likes Narrowing post #34, because the general version has more than one answer. Significant figures in the output should not exceed what the inputs support. A concentration…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #19 · Sourcing › Red flags · 20 Mar 2026 · 18 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
-
Transporting a vial for a weekend away — a second dataset Replied, post #3 · Practice › Storage & stability · 6 Mar 2026 · 0 likes The opening post put the caveat in the right place and I want to underline it. An update on my earlier Transporting a vial post: the pattern held for another six weeks…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #76 · Practice › Dosing & titration · 19 Feb 2026 · 0 likes Post #75 put the caveat in the right place and I want to underline it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #41 · Clinical › Special populations · 13 Feb 2026 · 0 likes Confirming post #40 from a second method, which matters more than confirming it from a second person. Dedicated trials in under-studied populations are the only real…
-
Second pass at: Identical chromatograms across two different lots Replied, post #3 · Sourcing › Red flags · 11 Feb 2026 · 12 likes This follows the opening post rather than contradicting it. Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #124 · Analytics › COA interpretation · 3 Feb 2026 · 6 likes "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying only the first has not told you what was measured. Happy to be the…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #91 · Clinical › Special populations · 26 Jan 2026 · 1 like Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment. Adding a source would improve this…
-
What to include when your question involves a chromatogram Replied, post #20 · Start Here › How to Ask · 4 Jan 2026 · 7 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #4 · Practice › Administration · 29 Dec 2025 · 33 likes Where the Pinch reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #31 · Practice › Side effects · 27 Dec 2025 · 30 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
DXA precision and the least significant change for lean mass Replied, post #44 · Outcomes › Body composition · 5 Dec 2025 · 25 likes The most useful reply I ever got about DXA precision was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #12 · Compounds › Other compounds · 22 Nov 2025 · 3 likes The practical version of Sequence verification is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Pricing far outside the range, in either direction Replied, post #5 · Sourcing › Red flags · 19 Oct 2025 · 2 likes Picking up post #4: that is the part I would want checked first. The honest answer on pricing far outside the range is that it depends, and the useful part is the list…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #91 · Lounge › Off topic · 12 Oct 2025 · 11 likes Digression worth the space: the archive is starting to be genuinely long. There are questions here whose good answer is four years old and still correct, and that only…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #98 · Practice › Administration · 7 Oct 2025 · 28 likes A note on how pinch gets discussed rather than on pinch itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
-
Documentation that materially improves an appeal's chances Replied, post #13 · Access › Insurance & coverage · 29 Sep 2025 · 9 likes Post #11 answers the question as asked. The question underneath it is different. Templates in the documentation set are deliberately dull because dullness is what works…
-
When to stop reading forums, including this one Replied, post #30 · Wellbeing › Mental health · 27 Sep 2025 · 13 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. Motivation and expectation: starting with clear motivation and realistic…
-
What a confidence interval means, from scratch — the long version Replied, post #2 · Research Methods › Statistics · 25 Sep 2025 · 0 likes The opening post answers the question as asked. The question underneath it is different. A confidence interval is a statement about a procedure rather than about this…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #53 · Sourcing › Vendor reports · 8 Sep 2025 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #133 · Practice › Storage & stability · 6 Sep 2025 · 0 likes Everything in post #129 holds. The case it does not cover is the one I have. If someone has run published stability data actually covers properly I would rather read…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #81 · Evidence › Trials · 27 Aug 2025 · 1 like The failure mode on Sample size calculations is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #28 · Compounds › Oral incretins · 24 Aug 2025 · 10 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
-
Research-use-only labelling: what it means and what it does not Replied, post #22 · Sourcing › Regulatory · 15 Aug 2025 · 2 likes Post #20 and I disagree about the size of the effect, not about the direction. The claim about research-use-only labelling upthread is stronger than its source…
-
A request that was declined, and the reasoning — a second dataset Replied, post #66 · Documentation › Wiki requests · 12 Aug 2025 · 31 likes Post #65 answers the question as asked. The question underneath it is different. Documents that are mostly a worked example age better than documents that are mostly a…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #16 · Analytics › Method validation · 5 Aug 2025 · 26 likes Everything in post #12 holds. The case it does not cover is the one I have. Range and working range are different things and a certificate rarely distinguishes them.…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #2 · Data & Tools › Datasets · 14 Jul 2025 · 1 like Everything in the opening post holds. The case it does not cover is the one I have. Independent test results are the most valuable data this community collects, and…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #36 · Devices › Syringes & needles · 13 Jul 2025 · 0 likes Coming back to post #32, because the follow-up matters more than the original answer. I have three months of notes on Filter needles and the honest summary is that the…
-
Comparing my trajectory with the trial curves, carefully Replied, post #20 · Outcomes › Progress reports · 3 Jul 2025 · 22 likes Narrowing post #17, because the general version has more than one answer. Nothing here is medical advice and a progress report is a description of what happened to one…
-
Repeatability versus intermediate precision Replied, post #39 · Analytics › Method validation · 22 Jun 2025 · 9 likes Building on post #38 rather than restating it. A definition problem is doing most of the work in this repeatability versus intermediate precision discussion. Once the…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #29 · Analytics › Home & field testing · 21 Jun 2025 · 6 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #6 · Compounds › Repair & healing peptides · 3 Jun 2025 · 2 likes Post #3 is right about the mechanism and I think understates the practical bit. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 2 Jun 2025 · 10 likes Everything in post #46 holds. The case it does not cover is the one I have. The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a…
-
Counter-ion content and its effect on measured mass Replied, post #47 · Analytics › Mass spectrometry · 25 May 2025 · 0 likes Post #46 is the version of this I will quote in future. One addition. Adding a reference point for counter-ion content. Mine is a single case, collected without…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #82 · Wellbeing › Mental health · 1 May 2025 · 0 likes My understanding of anxiety is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #110 · Evidence › Journal club · 22 Apr 2025 · 0 likes Narrowing post #107, because the general version has more than one answer. Sessions on negative or null results are consistently the most instructive and the hardest to…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #3 · Clinical › Bloodwork · 3 Apr 2025 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. Glycaemic markers integrate over different periods. A point glucose and a…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #8 · Clinical › Comorbidities · 26 Mar 2025 · 17 likes This follows post #7 rather than contradicting it. One caution on hepatic steatosis: everything above assumes the underlying documentation is what it claims to be. That…
-
About the Progress reports category Replied, post #3 · Outcomes › Progress reports · 26 Mar 2025 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #39 · Access › Pricing · 20 Mar 2025 · 13 likes Compute cost per delivered dose at your dose if you want a number you can act on. Everything else is a comparison of packaging. The short answer was in the first line;…
-
Charge states for a 4 kDa peptide, worked through Replied, post #103 · Analytics › Mass spectrometry · 14 Mar 2025 · 17 likes Adding a small correction to the charge states summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #69 · Analytics › COA interpretation · 11 Mar 2025 · 20 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #63 · Pharmacology › Receptor biology · 8 Mar 2025 · 9 likes A note on scope: what I am saying about biased agonism applies to the case in the first post and I would not extend it further without checking.
-
When to suspect the method rather than the sample Replied, post #55 · Analytics › Method validation · 24 Dec 2024 · 0 likes Post #53 and I disagree about the size of the effect, not about the direction. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #25 · Compounds › Semaglutide · 21 Dec 2024 · 1 like Adding a small correction to the Semaglutide formulation summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #17 · Start Here › Welcome · 16 Dec 2024 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: When to suspect the method rather than the sample Replied, post #52 · Analytics › Method validation · 10 Dec 2024 · 7 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #49 · Access › Insurance & coverage · 1 Dec 2024 · 7 likes I would rather this thread reach "we do not know" about Step therapy requirements than reach a confident answer that nobody can support when asked.
-
Why "any advice?" is the least effective ending for a post Replied, post #39 · Start Here › How to Ask · 15 Nov 2024 · 6 likes The arithmetic in post #38 is right; the assumption feeding it is the part to check. Edit the first post rather than adding the missing detail in reply nine. People…
-
When "no data" is the complete and final answer Replied, post #17 · Compounds › Other compounds · 8 Nov 2024 · 1 like Post #15 and I disagree about the size of the effect, not about the direction. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #63 · Compounds › Other compounds · 21 Oct 2024 · 27 likes Picking up post #62: that is the part I would want checked first. Where I have landed on Melanocortin agonists, having got it wrong once in public: the direction is…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #123 · Clinical › Bloodwork · 19 Oct 2024 · 3 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. Small point, but it is the one that usually catches…
-
Requesting a page: what makes a good request — what changed since Replied, post #21 · Documentation › Wiki requests · 9 Oct 2024 · 26 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Second pass at: Reimbursement variation across member states Replied, post #10 · Regional › European Union · 17 Sep 2024 · 5 likes Where I part company with post #8, and it is a narrow parting. Reframing Reimbursement variation across member states slightly, because I think the disagreement is…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #15 · Practice › Administration · 8 Sep 2024 · 0 likes The arithmetic in post #14 is right; the assumption feeding it is the part to check. If you have to inject at a different time of day than usual, that is a much smaller…
-
Correlation in a self-tracked dataset: what it can support Replied, post #60 · Research Methods › Statistics · 22 Aug 2024 · 0 likes I read post #58 twice before replying, because I had assumed the opposite. My experience of correlation contradicts the reply above. I am posting it as a data point…
-
Circumference measurements as a poor man's composition estimate Replied, post #14 · Outcomes › Body composition · 23 Jul 2024 · 14 likes Building on post #13 rather than restating it. On circumference measurements, I would rather understate and be corrected upward than overstate and be quoted. That is a…
-
The mass-error checker and its intended scope Replied, post #79 · Data & Tools › Calculators · 27 Jun 2024 · 0 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives. Happy to be the one who is…